Pinned Tweet
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
#ESMO26 Congress opens tomorrow in Madrid.
EORTC researchers and collaborators will present multidisciplinary research across oral presentations, mini orals, posters, e-posters and trials in progress.
Explore our abstract overview: eortc.org/blog/2026/10/22/eo…
👏 Proud of the strong contribution from the EORTC Quality of Life Group at #ISOQOL 2026, showcasing research that helps strengthen patient-centred cancer care and gives greater visibility to patients' experiences.
👇
#QualityofLife #GivingVoice2Patients #CancerResearch
@ISOQOL
📢 New questionnaires, interpretation guidelines, survivorship tools, paediatric oncology research & initiatives to improve the use of PROs: discover the key @EORTC #QualityofLife Group research presented at #ISOQOL 2026.
🔗 eortc.org/blog/2026/10/21/eo…
#GivingVoice2Patients
@ISOQOL
🎀 #PinkOctober: Can genomic testing help avoid unnecessary chemotherapy in breast cancer? Meet Betty, a participant in the MINDACT study.
Learn more: eortc.org/blog/2026/10/07/pi…
🎥 Watch her story:
@JulesBordet
#MINDACT #EORTCbreast
EORTC retweeted
📖 Yesterday afternoon at #ISOQOL, @monika_sztankay presented the @EORTC Patient-Reported Outcome Interpretation Guideline.
The project also introduces new resources to help patients understand EORTC PRO data, coming soon on our website.
#GivingVoice2Patients #QualityofLife
What does it take to move from protocol to patient?
Today at @EANM_NucMed 2026, our past president, @Winette_vdGraaf, shared practical lessons from multinational academic clinical trials across Europe drawing on years of experience in international cancer research.
#EANM26
EORTC retweeted
💡 This afternoon at #ISOQOL, Andreia Moura shared findings on how to improve PROM completion in cancer clinical trials.
Key takeaways: reduce questionnaire redundancy, support patients, and ensure site staff understands the value of PRO data collection.
#GivingVoice2Patients
📊 We're hiring a Senior Statistician to support the design, analysis and reporting of international clinical trials at EORTC.
Join a multidisciplinary team advancing cancer research through data-driven science.
🔗 Apply now: eortc.org/job/senior-statist…
#ClinicalTrials
📍 At #EANM26? Visit EORTC at booth 11 in the Society Village!
Don't miss our Joint Symposium today at 15:00 in Hall F2 on clinical trial design for RLTs.
@EANM_NucMed
#ClinicalTrials #CancerResearch #RadioligandTherapy #RLT #Oncology
📢 EORTC is at #EANM26!
Among the programme highlights are a joint symposium with the EANM Oncology & Theranostics Committee on evidence generation for radioligand therapies and a presentation by Winette Van der Graaf on multinational academic trials across Europe.
@EANM_NucMed
50 years of supporting progress in cancer research!
Relive the highlights of the EORTC Cancer Research Fund's anniversary Gala Dinner and celebrate five decades of impact.
Watch the aftermovie: ow.ly/FZF150ZYsYU
#EORTC #ECRF #CancerResearch
🚨 Final days to submit your LBA!
Last chance to share your latest research with the ENA community.
Deadline: This Monday
👉 Submit now: event.eortc.org/ena2026/late…
@AACR @theNCI
#ENASymp26 #CancerResearch #Oncology
Proud to see the EORTC Quality of Life Group presenting 16 abstracts at #ISOQOL 2026 next week, contributing to advances in patient-centred cancer research.👇
#QualityofLife #GivingVoice2Patients #CancerResearch @ISOQOL
We are looking forward to #ISOQOL 2026 in Prague! 🇨🇿
The @EORTC #QualityofLife Group will present 16 abstracts (6 oral, 10 poster) showcasing advances in PRO & HRQoL research, paediatric oncology, survivorship and questionnaire development.
🔗 eortc.org/blog/2026/10/15/eo…
@ISOQOL
📢 We're hiring an EU Grant Officer.
If you have experience with EU-funded projects and enjoy working in an international research environment, we'd like to hear from you.
🔗Apply here: eortc.org/job/eu-grant-offic…
#Hiring #EORTC #CancerResearch #EUJobs
How can Europe better support low-risk, treatment optimisation trials?
Among the Top 3 abstracts at the ECO Summit, this new EORTC study compares EU, UK and Swiss frameworks for low-intervention clinical trials and calls for more proportionate regulation.
doi.org/10.1016/j.ejca.2026.…
🎀#PinkOctober: How do treatment decisions impact patients decades later?
EORTC-22922/10925 trial: 20-year follow-up includes a node-negative analysis published in @TheLancetOncol, exploring regional lymph node irradiation.
🎥Watch now
🔗eortc.org/blog/2026/10/07/pi…
#EORTCbreast
📢 We're hiring a Medical Liaison Officer (MLO)!
Join the EORTC Medical Department and help support our scientific groups, committees and international cancer research activities.
🔗 Apply here: eortc.org/job/medical-liaiso…
#WeAreHiring #CancerResearch
Europe's leadership in biotechnology depends on turning innovation into real-world patient benefit.
EORTC CEO Denis Lacombe is participating in today's Expert Dialogue on the EU Biotech Act at the @Europarl_EN, bringing the academic cancer research perspective.
🚨 LBA submission is OPEN!
Share your latest, practice-changing research with the ENA community. Submit by 19 October!
👉 event.eortc.org/ena2026/late…
@AACR @theNCI
#ENASymp26 #CancerResearch #Oncology
📢 EORTC's new President, Prof. @BenjaminBesseMD, discusses the future of academic clinical cancer research, including the future generation of researchers, patient involvement, quality of life, and the transformative potential of AI.
Read the interview with @touchONCOLOGY 👇
What does the future hold for academic cancer research? 🧬
Professor Benjamin Besse, President of the European Organisation for Research and Treatment of Cancer (@EORTC) discusses his priorities for advancing cancer research while keeping patients at the centre.
In this Q&A, he explores the need for more representative clinical trials, greater emphasis on quality of life and patient involvement, and the role of emerging technologies, including artificial intelligence, in shaping future research.
Read the full interview: touchoncology.com/insight/pr…
#touchONCOLOGY #EORTC #CancerResearch #Oncology #ClinicalTrials
EORTC retweeted
We celebrate our Autumn @EORTC Lung Cancer Group Meeting! 🍂 Academic trials are increasingly challenging but essential to answer questions that shape patient care. Great future ideas and fruitful discussions! You’re welcome to Join our group! @HendriksLizza Brandao @EORTC
